Closed System Transfer Devices Market Segmentation:
End-user Segment Analysis
The hospitals & clinics segment is anticipated to hold the largest market share by the end of 2035, attributed owing to the great financial power of hospitals to afford high-ranged CSTSs, the growing prevalence of cancer, and the requirement imposes some regulatory guidelines. According to the American Cancer Society, an estimated 1.9 million new cancer cases were diagnosed in the United States in 2021, with approximately 608,570 deaths from cancer. The acceptance of closed system transfer devices (CSTDs) in healthcare has increased significantly in recent years. Several factors have contributed to this trend, including increased awareness of the risks associated with exposure to hazardous drugs, regulatory requirements, and technological improvements oncology medical devices, and many more. The use of closed-system transfer devices in hospitals is also driven by regulatory requirements. Several regulatory agencies, such as the Occupational Safety and Health Administration (OSHA) and the National Institute for Occupational Safety and Health (NIOSH), have issued guidelines recommending the use of closed system transfer devices for hazardous drug handling in healthcare facilities.
Type Segment Analysis
The membrane-to-membrane segment is anticipated to account for the largest market share by the end of 2035. The huge share and the growth of this segment can be attributed owing to the simplicity of operation and low risk of contamination associated with the double membrane containment system.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Technology |
|
|
By End User |
|
